The expression levels of KDM5C and PFDN5 were then assessed in the clinical samples.The IHC assay revealed a higher proportion of KDM5C-positive cells and a lower proportion of PFDN5-positive cells in CRC tissues compared to adjacent normal tissues (Fig. 2A, B). The gene discussed is KDM5C; the disease is colorectal carcinoma.